Elutia (ELUT) EPS (Diluted) Growth (1y) (2021 - 2026)
Powered by 
Analysis
Elutia (ELUT) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.79 Bn | 175.19 Bn | 7.27 Bn | -47.60% |
| 2 | Intuitive Surgical | 127.05 Bn | 121.83 Bn | 1.96 Bn | 26.30% |
| 3 | Medtronic | 117.00 Bn | 108.18 Bn | 6.34 Bn | 41.58% |
| 4 | Stryker | 103.78 Bn | 100.31 Bn | 4.50 Bn | 44.49% |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 15.24% |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | -25.88% |
| 7 | Alcon | 32.98 Bn | 31.52 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.05 Bn | 30.10 Bn | 830.00 Mn | 44.97% |
| 9 | Steris | 20.68 Bn | 20.19 Bn | 684.20 Mn | 13.96% |
| 10 | Elutia | 36.01 Mn | 16.11 Mn | 1.45 Mn | 16.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.69% |
| Mar 31, 2026 | -89.53% |
| Dec 31, 2025 | -75.35% |
| Sep 30, 2025 | -374.22% |
| Jun 30, 2025 | 81.66% |
| Mar 31, 2025 | 87.82% |
| Dec 31, 2024 | 317.00% |
| Sep 30, 2024 | 105.24% |
| Jun 30, 2024 | -72.87% |
| Mar 31, 2024 | -24.25% |
| Dec 31, 2023 | -63.44% |
| Sep 30, 2023 | 29.06% |
| Jun 30, 2023 | 5.12% |
| Mar 31, 2023 | -0.89% |
| Dec 31, 2022 | 49.89% |
| Sep 30, 2022 | 0.63% |
| Jun 30, 2022 | -195.92% |
| Mar 31, 2022 | -21.16% |
| Dec 31, 2021 | 53.78% |
| Sep 30, 2021 | 94.86% |